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        Despite signifi  cant advances over the past two 
decades with respect to our understanding of the 
immune response to HIV-1 infection, the precise 
immune correlates of protection against HIV-1 
disease progression are still largely unknown. 
Epidemiological studies have identifi  ed several 
host genetic factors that are strongly associated 
with better HIV-1 disease outcome. A 32  –  base-
pair deletion in CC chemokine receptor (CCR) 
5 is associated with an increased resistance to 
infection (  1  –  3  ). Furthermore, a signifi  cant pro-
tective eff  ect from HIV-1 disease progression 
has been described for several human leukocyte 
antigen (HLA) class I alleles, whereas an asso-
ciation with more rapid disease progression 
has been described for other HLA class I alleles 
(  4  –  6  ). These studies suggest a critical role for 
HIV-1  –  specifi  c CD8  +   T cells in the control of 
viral replication and have helped guide func-
tional studies in the area of T cell immunology 
in HIV-1 infection. More recently, a signifi  cant 
association has been described between slower 
HIV-1 disease progression and the expression 
of an activating NK cell receptor, the killer 
immunoglobulin-like receptor (KIR) 3DS1, in 
conjunction with its putative ligand, HLA-B 
Bw4 alleles with an isoleucine at position 80 
(referred to as HLA-B Bw4-80I) (  7  ). This pro-
tective eff  ect was independent of the expression 
of the respective HLA-B Bw4-80I alleles HLA-
B57 or HLA-B27 (  7  ). These epidemiological 
data were the fi  rst to implicate specifi  c NK cell 
receptor genes in modulating HIV-1 patho-
genesis, but the functional basis of the epidemi-
ological association between these KIR/HLA 
compound genotypes and control of HIV-1 
replication and disease progression have not yet 
been identifi  ed. 
  NK cells are the primary eff  ector cells of the 
innate immune response, as they are able to lyse 
virally infected cells and secrete large amounts of 
proinfl  ammatory cytokines/chemokines without 
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  Decline of peak viremia during acute HIV-1 infection occurs before the development of 
vigorous adaptive immunity, and the level of decline correlates inversely with the rate of 
AIDS progression, implicating a potential role for the innate immune response in determining 
disease outcome. The combined expression of an activating natural killer (NK) cell receptor, 
the killer immunoglobulin-like receptor (KIR) 3DS1, and its presumed ligand, human 
  leukocyte antigen (HLA)  –  B Bw4-80I, has been associated in epidemiological studies with a 
slow progression to AIDS. We examined the functional ability of NK cells to differentially 
control HIV-1 replication in vitro based on their KIR and HLA types. NK cells expressing 
KIR3DS1 showed strong, signifi  cant dose- and cell contact  –  dependent inhibition of HIV-1 
replication in target cells expressing HLA-B Bw4-80I compared with NK cells that did not 
express KIR3DS1. Furthermore, KIR3DS1  +   NK cells and NKLs were preferentially activated, 
and lysed HIV-1 infected target cells in an HLA-B Bw4-80I  –  dependent manner. These data 
provide the fi  rst functional evidence that variation at the KIR locus infl  uences the effec-
tiveness of NK cell activity in the containment of viral replication. 3028 NK CELL  –  MEDIATED INHIBITION OF HIV-1 | Alter et al.
evaluations of this in vitro system demonstrated that freshly 
isolated NK cells were able to inhibit HIV-1 replication in 
autologous HIV-1  –  infected CD4  +   T cells. NK cells   persisted 
throughout the 14-d culture and acquired an activated pheno-
type expressing high levels of CD56, KIR, NKp46, CD161, 
and NKG2D (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20070695/DC1). 
  Results for the inhibition of viral replication at   diff  erent E/T 
ratios showed high concordance when tested in three sepa-
rate experiments on cells derived from the same individuals 
(small standard deviations), as demonstrated for a representa-
tive individual in   Fig. 1 A  .   Furthermore, NK cell  –  mediated 
inhibition of HIV-1 replication in autologous CD4  +   T cells 
was dependent on the number of NK cells added into CD4  +   
T cell cultures (  Fig. 1, A and B  ), further suggesting that NK 
cells are directly responsible for the inhibition of HIV-1 rep-
lication observed in this system. The level of viral replication 
peaked by day 7 after infection, and at that time the strongest 
NK cell  –  mediated inhibition of HIV-1 replication was ob-
served, expressed as the log diff  erence in p24 Gag produc-
tion between CD4  +   T cells alone or in the presence of NK 
cells (  Fig. 1, A and B  ). Collectively, these data demonstrate 
that the ability of NK cells to inhibit HIV-1 replication can 
be quantifi  ed in vitro and that the inhibition of viral replica-
tion depends on the NK eff  ector cell/CD4  +   T cell target 
ratios used. 
  NK cells suppress the spread of HIV-1 infection in vitro 
  Although the production of p24 Gag is a strong surrogate 
marker for the level of viral replication in vitro, it does not 
allow for the determination of whether the observed suppres-
sion of p24 Gag production is caused by the continuing in-
fection of CD4  +   T cell targets but reduced virion release, or 
by the reduction of the number of infected CD4  +   T cells. 
We used intracellular p24 staining on infected T cells at 3  –  4-d 
intervals to quantify the number of infected cells over time 
and observed a signifi  cantly lower proportion of p24  +   T cells 
in wells containing NK cells and CD4  +   T cells at an E/T ratio 
of 10:1 compared with wells containing HIV-1  –  infected CD4  +   
T cells alone or NK cells at lower E/T ratios (  Fig. 1 C   and 
Fig. S2, available at http://www.jem.org/cgi/content/full/jem
.20070695/DC1). Given that only NK cells (CD3    −   CD56  +/      
CD16  +/      ) and CD4  +   T cells (CD3  +  CD4  +  ) cells were present 
in the co-cultures, we stained cells with CD3 to distinguish 
these two populations and assessed the level of p24 in cells 
expressing CD3. Overall, p24 Gag production quantifi  ed in 
the supernatant by ELISA was signifi  cantly correlated to the 
percentage of p24  +   CD3  +   T cells quantifi  ed by fl  ow cyto-
metry (r= 0.66; P = 0.002). These results demonstrate that 
the observed NK cell  –  mediated inhibition of HIV-1 replica-
tion was caused by the containment of HIV-1 infection to a 
small subset of CD4  +   T cells. 
  NK cells require contact to mediate HIV-1 inhibition 
  NK cells are involved in the control of viral infection both via 
the release of antiviral cytokines and the direct lysis of target 
prior antigen sensitization (  8  ). NK cells play a critical role in 
the control of viral replication in several disease models (  9  –  11  ), 
and depletions or defi  ciencies of NK cells lead to signifi  -
cantly more severe viral disease and death in both mice and 
humans (  12, 13  ). In addition to the protective eff  ect of the 
KIR3DS1/HLA-B Bw4-80I compound genotype in HIV-1 
infection (  7  ), the protective eff  ects of particular KIR/HLA 
genotypes have been demonstrated in several other epidemi-
ological studies in human viral infections, including hepatitis 
C virus (  14  ), human papillomavirus (  15  ), and CMV reactiva-
tion after transplantation (  16  ), suggesting that the interaction 
between KIRs and their HLA class I ligands can have a pro-
found impact on the effi   cacy of NK cell  –  mediated control of 
viral pathogenesis (  17  ). 
  As many as 15 diff  erent KIRs have been identifi  ed (  18  ), 
and this family of glycoprotein receptors expressed predomi-
nantly on NK cells can be grouped into categories based on 
whether they possess two or three immunoglobulin-like 
domains (  18  ). They are also characterized by long or short cyto-
plasmic tails that transmit inhibitory or activating signals, 
respectively (  18  ). KIR3DS1 has been recently shown to be 
expressed on the surface of NK cells (  19, 20  ) and to associate 
with Dap12 (  19  ), a characteristic of activating NK cell recep-
tors. Although the precise ligand for KIR3DS1 has not been 
identifi  ed, HLA class I molecules of the HLA-B Bw4-80I 
family have been proposed as putative ligands, as KIR3DS1 
shares   >  97% sequence homology in the extracellular domains 
with KIR3DL1, an inhibitory KIR that interacts with several 
HLA-B Bw4-80I molecules (  18, 21  –  24  ). 
  We hypothesized that the observed epidemiological asso-
ciation of the KIR3DS1/HLA-B Bw4-80I genotype with 
slower HIV-1 disease progression is caused by the ability of 
KIR3DS1  +   NK cells to strongly inhibit HIV-1 replication in 
HLA-B Bw4-80I  +   CD4  +   T cells, and we developed an in vitro 
viral replication inhibition assay to test this hypothesis. In this 
paper, we demonstrate that NK cells are able to suppress 
HIV-1 replication in vitro in a dose- and cell contact  –  dependent 
manner. Furthermore, we show that NK cells expressing 
KIR3DS1 strongly and signifi  cantly inhibited HIV-1 replica-
tion in target cells expressing HLA-B Bw4-80I relative to NK 
cells that do not express KIR3DS1. These data provide the 
fi  rst functional evidence that variation at the KIR locus infl  u-
ences the eff  ectiveness of NK cell activity in the containment 
of HIV-1 replication. 
    RESULTS   
  NK cells can suppress HIV-1 replication in vitro 
  To determine the anti-HIV-1 activity of NK cells in vitro, 
we developed a co-culture assay to measure the level of HIV-1 
replication in CD4  +   T cells in the presence or absence of 
autologous NK cells. In this assay, purifi  ed activated CD4  +   T 
cells were infected with HIV-1 and coincubated with puri-
fi  ed autologous NK cells at diff  erent eff  ector/target (E/T) ra-
tios over a period of 14 d in the presence of IL-2, and HIV-1 
replication was quantifi  ed using a p24 Gag ELISA. The initial JEM VOL. 204, November 26, 2007 
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cells and HIV-1  –  infected CD4  +   T cells were in contact 
  during co-culture was added on days 3, 7, 10, and 14 to wells 
containing only autologous HIV-1  –  infected CD4  +   T cells. 
Supernatant alone mediated some viral suppression over the 
course of the 14-d period (  Fig. 1 E  ), albeit at signifi  cantly 
lower levels than in wells where the cells were in direct con-
tact. Collectively, these data demonstrate that direct cell-to-
cell contact between NK cells and autologous HIV-1 –  infected 
CD4  +   T cells is required to trigger the inhibition of HIV-1 
replication in this system, and that secreted factors alone are 
not suffi   cient to mediate signifi  cant inhibition. 
  Subjects expressing KIR3DS1 and HLA-B Bw4-80I suppress 
HIV-1 replication most potently compared with individuals 
expressing only one or none of these alleles 
  To assess the impact of the   KIR/HLA   compound geno-
type on the ability of NK cells to inhibit HIV-1 replication 
in vitro, NK cell  –  mediated inhibition of viral replication 
was quantifi  ed in a group of 36 HIV-1  –  negative study subjects 
expressing a diverse array of  KIR/HLA   genotypes. As demon-
strated in   Fig. 2 A  , the level of NK cell  –  mediated inhibition 
of HIV-1 replication in autologous CD4  +   T cells in vitro 
diff  ered largely among the 36 subjects tested, ranging from 0 
to 2.1 logs at day 7, when inhibition of viral replication was 
most pronounced.   
  To test the initial hypothesis that NK cells derived from 
individuals with the   KIR3DS1/HLA-B Bw4-80I   compound 
genotype mediate strong antiviral activity, the study sub-
jects were grouped according to their genotype (  KIR3DS1/
Bw4-80I  ,   n   = 8;   KIR3DS1   alone,   n   = 8; Bw4 alone,   n   = 10; 
and neither gene,   n   = 10). As early as day 3, NK cells derived 
from subjects possessing both   KIR3DS1   and   HLA-B Bw4-
80I   alleles exhibited a superior level of viral inhibition com-
pared with NK cells derived from subjects who had one of 
the two or neither of the alleles (  Fig. 2 B  ); these diff  erences 
reached statistical signifi  cance at days 7, 10, and 14 (P   <   0.01 
for comparisons of each group versus   KIR3DS1  +  /Bw4-80I  +    ). 
In contrast, the ability of HIV-1 to replicate in CD4  +   T cells 
in the absence of NK cells did not diff  er across the four geno-
typic groups (P   >   0.3 for comparisons of p24 Gag levels be-
tween each group versus   KIR3DS1  +  /Bw4-80I  +    ; Fig. S2 C), 
demonstrating that the inhibition of viral replication was 
caused by diff  erences in the antiviral activity of the added 
NK cells and not by diff  erences in the ability of the virus to 
replicate in the diff  erent CD4  +   T cell populations studied. 
Data presented in   Fig. 2   were derived from experiments 
  using a CCR5-tropic HIV-1 strain derived from a clinical 
sample; however, similar suppressive activity was observed 
with CCR5-tropic laboratory-adapted strains and CXCR4-
tropic strains (unpublished data). These data demonstrate that 
NK cells derived from subjects with the compound genotype 
  KIR3DS1/HLA-B Bw4-80I   exhibit strong anti  –  HIV-1 ac-
tivity in vitro and for the fi  rst time provide functional data in 
support of a plausible mechanistic basis for the described epi-
demiological association between this genotype and slower 
HIV-1 disease progression. 
cells (  25  ). To determine whether NK cells require contact 
with infected cells to mediate viral inhibition, NK cells and 
HIV-1  –  infected CD4  +   T cells were separated in transwell 
  experiments at an E/T ratio of 10:1. No signifi  cant inhibi-
tion of HIV-1 replication was observed when NK cells and 
auto  logous infected CD4  +   T cells were separated by a semiper-
meable membrane (  Fig. 1 D  ), demonstrating that direct cell-
to-cell contact was required for the initial triggering of NK 
cell activity and/or for mediating their antiviral activity. 
  Furthermore, to determine whether secreted factors from 
NK cells alone were suffi   cient to inhibit viral replication 
in vitro, supernatant collected from experiments in which NK 
  Figure 1.     NK cells are able to mediate inhibition of HIV-1 replica-
tion in a contact-dependent manner. (A) The line graph depicts the 
mean change in the viral load (log10 p24 Gag in supernatant) observed in 
a single subject from three separate experiments in wells containing CD4  +  
T cells alone (continuous black line), and NK cells and autologous CD4  +   T 
cells at a ratio of 10:1 (short dashed black line), 1:1 (long dashed gray 
line), and 1:10 (long dashed black line). (B) The fi  gure represents a log 
reduction in p24 Gag production at different NK cell/CD4  +   T cell ratios 
(10:1, 1:1, and 1:10) for days 3, 7, 10, and 14 (  n   = 5). (C) The whisker box 
plots show the percentage of p24 Gag  +   CD3 +   T cells at days 3, 7, 10, and 
14 in wells containing NK cells at different NK cell/CD4  +   T cell ratios (10:1, 1:1, 
and 1:10;   n   = 6). (D) The fi  gure represents the log inhibition of HIV-1 
replication observed on days 3, 7, 10, and 14 in wells where NK cells and 
autologous HIV-1  –  infected CD4  +   T cells were co-cultured together (gray) 
or separated in a transwell experiment (black) at an NK cell/CD4  +   T  cell 
ratio of 10:1 (  n   = 5). (E) The whisker box plots show the log inhibition of 
HIV-1 replication observed on days 3, 7, 10, and 14 in wells where NK cells 
and autologous HIV-1  –  infected CD4  +   T cells were co-cultured together 
(gray) at an NK cell/CD4  +   T cell ratio of 10:1, or where the supernatant 
was transferred from co-cultured cells to autologous HIV-1  –  infected 
CD4  +   T cells (black;   n   = 5). Data represent the mean of at least three ex-
periments and standard deviations.     3030 NK CELL  –  MEDIATED INHIBITION OF HIV-1 | Alter et al.
(a) NK cells that express neither KIR3DS1 nor KIR3DL1 
(z27  neg  DX9  neg  ;   Fig. 3  ), (b) NK cells expressing KIR3DS1 
alone (z27  lo  DX9  neg  ;   Fig. 3  ), and (c) NK cells expressing 
KIR3DL1 alone or in conjunction with KIR3DS1 (z27  hi  DX9  pos  , 
as both of these populations are included in the medium-high 
MFI population [  19  ];   Fig. 3 A  ).   
  The respective NK cell populations were individually 
sorted from PBMCs derived from fi  ve HLA-B Bw4-80I  +   in-
dividuals expressing both KIR3DS1 and KIR3DL1 using an 
extreme gating strategy to guarantee the sorting of highly puri-
fi  ed subpopulations of NK cells (  Fig. 3 A  ), and they were used 
separately as eff  ector cells in a viral replication inhibition assay 
with autologous HIV-1  –  infected CD4  +   T cells at an E/T ratio 
of 10:1. Notably, inhibition of HIV-1 replication mediated by 
the KIR3DS1  pos  KIR3DL1  neg   NK cell populations was signifi  -
cantly greater than that mediated by the KIR3DL1  pos   subset of 
NK cells (1.48 vs. 0.3 logs; P = 0.01;   Fig. 3 B  ). The KIR3DS1  pos   
subset also mediated greater viral inhibition than the KIR3D-
S1  neg  KIR3DL1  neg   NK cells (1.48 vs. 0.79 logs; P = 0.04). 
  KIR3DS1  +   NK cells are mainly responsible for the 
suppression of HIV-1 replication 
  KIR molecules are expressed in a stochastic, variegated man-
ner on NK cells within a given individual, giving rise to NK 
cell clones with distinct KIR expression profi  les in that indi-
vidual (  26  ). This results in the presence of both KIR3DS1  pos   
and KIR3DS1  neg   NK cell populations in an individual who 
has the allele encoding for KIR3DS1. To determine whether 
the KIR3DS1  pos   NK cell populations from subjects express-
ing KIR3DS1 and HLA-B Bw4-80I were responsible for the 
observed in vitro suppression of HIV-1 replication, we used 
two monoclonal antibodies  —  one directed against KIR3DL1 
(DX9) and one directed against both KIR3DL1 and KIR3DS1 
(z27) (  19  )  —  to sort the individual NK cell populations ex vivo. 
Although the DX9 antibody only labels KIR3DL1  pos   NK 
cells, z27 labels both KIR3DS1  pos   NK cells with a low mean 
fl  uorescence intensity (MFI) and KIR3DL1  pos   NK cells with a 
high MFI (  19, 27, 28  ). The combination of these antibodies 
with distinct specifi  cities allowed for the dissection of three sep-
arate NK cell populations, as previously described (  19, 20, 29  ): 
  Figure 3.     NK cells expressing KIR3DS1 inhibit HIV-1 replication 
more effectively and respond stronger to Bw4-80I  +   HIV-1  –  infected 
target cells. (A) The fl  ow plots demonstrate the segregation of KIR3DL1  +  
NK cells (1), KIR3DS1  + /KIR3DL1  −    NK cells (2), and NK cells expressing neither 
of these receptors (3), using the combination of the z27 and DX9 antibodies 
for a subject that does not encode KIR3DS1 (left) and one that does encode 
KIR3DS1 (right). Numbers represent the proportion of events present within 
that quadrant. (B). The dot plot represents the log inhibition of HIV-1 repli-
cation (given as log inhibition of p24 Gag production) in co-cultures of 
autologous  HIV-1 – infected  Bw4-80I +   CD4 +   T cells with bulk NK cells, sorted 
populations of KIR3DS1  + /3DL1  −    NK cells, KIR3DL1  +   NK cells, and NK cells 
expressing neither of these markers at an NK cell/CD4  +   T cell ratio of 10:1. 
All experiments were performed in triplicate in fi  ve different KIR3DS1  + /
KIR3DL1  +   subjects. Horizontal bars represent the mean log inhibition.    
  Figure 2.     NK cells derived from subjects with KIR3DS1 and HLA-B 
Bw4-80I suppress viral replication more effectively in vitro. (A) The 
dot plot demonstrates the heterogeneity of viral suppression (given as log 
inhibition of p24 Gag production) observed in the total cohort of 36 study 
subjects at an NK cell/CD4  +   T cell ratio of 10:1 (  n   = 36). Horizontal bars 
represent the mean log inhibition. (B) The whisker box plots represent the 
log inhibition observed in subjects with KIR3DS1 and HLA-B Bw4-80I 
(black;   n   = 8), HLA-Bw4 alone (light gray;   n   = 10), KIR3DS1 alone (white; 
  n   = 8), and individuals that express neither of these two alleles (dark gray; 
  n   = 10), where NK cells and CD4  +   T cells were co-cultured at an E/T ratio 
of 10:1. Data represent the mean and SDs. **, P   <   0.001; *, P   <   0.05.     JEM VOL. 204, November 26, 2007 
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HIV-1  –  infected Bw4 +   CD4 +   T cells, we monitored KIR3DS1 pos  /
3DL1  neg   and KIR3DL1  pos   NK cell degranulation in bulk NK 
cells derived from heterozygous KIR3DL1  +  /3DS1  +   individ-
uals (  30  ) after 7 d of co-culture with autologous Bw4  +   or 
Bw6  +   HIV-1  –  infected CD4  +   T cells. CD107a expression 
was increased fi   vefold in KIR3DS1  pos  /3DL1  neg   NK cells 
after exposure to HIV-1  –  infected Bw4  +   CD4  +   T cells but 
increased less than twofold after coincubation with HIV-1  –
  infected Bw6  +   CD4  +   T cells (P = 0.03;   Fig. 4, A and B  ).   
In contrast, very little increase in CD107a expression was 
observed on KIR3DL1  pos   NK cells after coincubation with 
autologous HIV-1  –  infected CD4  +   T cells irrespective of the 
HLA-B Bw genotype of the individual (  Fig. 4 B  , bottom). 
KIR3DL1  +   NK cells responded more potently to the MHC-
devoid target cells K562 or 221 than to KIR3DS1  +   NK cells, 
suggesting that the diff  erence observed after stimulation with 
HIV-1  –  infected autologous target cells was specifi  c to the 
Furthermore, the NK cell population that did not contain 
KIR3DS1  +   NK cells (the KIR3DL1    −   /3DS1    −    population) 
  inhibited HIV-1 replication to a lesser extent than bulk NK 
cells (0.8 vs. 1.33 logs; P = 0.06;   Fig. 3 B  ). The residual anti-
viral activity of the KIR3DS1  neg  KIR3DL1  neg   NK cells sug-
gests that other NK cell receptors in addition to KIR3DS1 
are also able to restrict HIV-1 replication to some extent, 
specifi  cally in the absence of KIR3DL1. Overall, these data 
demonstrate that KIR3DS1  pos   NK cells are largely responsi-
ble for the NK cell  –  mediated suppression of in vitro HIV-1 
replication observed in individuals expressing the   KIR3DS1/
HLA-B Bw4-80I   genotype. 
  KIR3DS1  +   NK cells preferentially lyse HIV-1  –  infected 
HLA-B Bw4-80I  –  expressing target cells 
  To further evaluate whether NK cells expressing KIR3DS1 
in the absence of KIR3DL1 were preferentially activated by 
  Figure 4.     KIR3DS1  +   NK cells are activated and lyse HIV-1  –  infected cells in the presence of HLA-B Bw4-80I alleles. (A) Using the combination 
staining of DX9 and z27, gates were set along the z27 axis to gauge the level of degranulation on z27  hi   (DX9 + z27 +   or  KIR3DL1 + ),  z27 dim   (DX9  −  z27 +   or 
KIR3DS1  +  ), or z27  neg   (DX9  −  z27  −    or double negative) NK cells after stimulation with (a) medium alone, (b) K562, (c) 221 cells, (d) uninfected autologous 
CD4  +   T cells, (e) autologous HIV  +   CD4 +   T cells, and (f) PMA/ionomycin. NK cells and target cells were plated at a ratio of 10:1 for all experiments. (B) The 
line graphs show the percentage of CD107a  +   NK cells derived from KIR3DS1  + /HLA-B  Bw4 +   (black lines) and KIR3DS1  + /HLA-B  Bw6 +   (gray lines) individuals 
after the culture of NK cell populations in the presence of autologous HIV-1  –  uninfected or   –  infected CD4  +   T cells (at a ratio of 10:1). Gating strategies 
were used to calculate the percentage of CD107a  +   NK cells within the KIR3DS1  +   NK cell population (z27  + DX9  −   ; top) or within the KIR3DL1  +   NK cell popu-
lation (z27  + DX9 +  ; bottom). Only KIR3DS1  + /3DL1  −    NK cells co-cultured with Bw4  +   HIV-1 – infected  CD4 +   T cells signifi  cantly (P = 0.03) up-regulated CD107a 
expression. (C) The whisker box plot represents the percentage of untransfected 221 cells that were lysed in a 6-h chromium assay using bulk NK cells 
derived from KIR3DS1  +   subjects (light gray;   n   = 6) and KIR3DS1   −    individuals (dark gray;   n   = 6). NK cells were co-cultured with Cr  51  -labeled targets at a 
ratio of 20:1. (D) The bar graph displays the ratio of the percent lysis of HIV-1  –  infected versus   –  noninfected, HLA-transfected 221 cells (with 52% of cells 
staining for p24 by intracellular fl  ow at the maximal time of infection) by a KIR3DS1-transfected NKL (NKL/221 target cell, 20:1;   n   = 3). Data represent 
the mean of at least three experiments and standard deviations.     3032 NK CELL  –  MEDIATED INHIBITION OF HIV-1 | Alter et al.
on HIV-1 disease progression (  7  ), implicating NK cells directly 
in the control of HIV-1 pathogenesis. 
  The expression of specifi  c KIRs in conjunction with their 
HLA ligands has been shown to have an impact on disease 
outcome in several epidemiological studies in diff  erent   human 
viral infections, including protection against HIV (  7, 31  ), 
hepatitis C virus (  14  ), CMV reactivation (  16  ), and, more re-
cently, protection against seroconversion in a group of female 
sex workers that were repeatedly exposed to HIV but re-
mained seronegative (  32  ). However, it is still unclear from 
these epidemiological studies what mechanism accounts for 
NK cell  –  mediated control of viral replication. In this paper, 
we demonstrate that NK cells are able to suppress HIV-1 viral 
replication in vitro. Furthermore, we show that KIR3DS1  +   
NK cells exert their antiviral activity preferentially in the 
presence of HLA-B Bw4-80I on HIV-1  –  infected target cells. 
Collectively, these data provide the fi  rst functional evidence 
that NK cells can contribute directly to the control of HIV-1 
replication in a receptor  –  ligand  –  specifi  c manner. 
  KIRs are stochastically expressed on NK cells. Thus, in a 
given KIR3DS1  +  /KIR3DL1  +   individual, a subset of NK cell 
clones expresses KIR3DS1 alone, a small subset may   express 
KIR3DS1 in combination with KIR3DL1 (  20  ), and others do 
not express KIR3DS1 at all. To address whether KIR3DS1  +   
NK cells preferentially mediated the inhibitory eff  ect on 
HIV-1 replication observed for subjects that encode this re-
ceptor, we used a gating strategy based on the combination of 
two KIR3DS1/KIR3DL1-specifi  c antibodies (DX9 and z27)
(  19, 20, 27  –  29  ) to sort populations of NK cells that expressed
KIR3DS1 and not KIR3DL1 (DX9    −    and z27  lo  ), KIR3DL1 
(DX9  +   and z27  hi  ), or neither of these two KIRs (DX9    −    and 
z27    −   ). Thus, using these individual NK cell popu  lations derived 
from the same individual, we demonstrate that KIR3DS1  +  /
KIR3DL1    −    NK cells were signifi  cantly more potent in me-
diating inhibition of HIV-1 replication relative to the other 
NK cell subpopulations. Furthermore, the NK cell popula-
tion that did not include KIR3DS1  +   NK cells (KIR3DL1    −   /
3DS1    −   ) inhibited HIV-1 replication to a lesser extent than 
bulk NK cells. The observation that KIR3DS1    −   /KIR3DL1    −    
NK cells were also able to mediate some viral inhibition 
(albeit at lower levels than KIR3DS1  +   NK cells) was in 
line with previous studies demonstrating that additional NK 
cell receptors, including natural cytotoxicity receptors, may 
also be involved in the recognition of HIV-1  –  infected target 
cells (  33, 34  ). 
  In contrast, little inhibition of HIV-1 replication was medi-
ated by NK cell populations expressing the inhibitory receptor 
KIR3DL1 (DX9  +   and z27  hi  ) despite the fact that these DX9/
z27 double-positive NK cells may also include a small fraction 
of NK cells that express both KIR3DL1 and KIR3DS1 (  20  ). 
Recent data demonstrate that particular KIR3DL1 haplotypes 
are in fact associated with slower HIV-1 disease progression 
(  31  ), suggesting that specifi  c KIR3DL1 subtypes may also be 
critically involved in the recognition of HIV-1  –  infected target 
cells, perhaps by monitoring for changes in the downmodula-
tion of MHC class I alleles by HIV Nef. Further studies are 
KIR3DS1  +   NK cell subpopulation (  Fig. 4 A  ). To eliminate 
the possibility that bulk NK cell populations derived from 
subjects that express KIR3DS1 were just intrinsically more 
potent at recognizing target cells, we further measured the 
lytic activity of bulk NK cell populations against HLA-  devoid 
chromium-labeled 221 cells. There was no diff  erence in the 
level of killing of 221 cells among subjects that possessed or 
did not possess the KIR3DS1 gene (  Fig. 4 C  ). Collectively, 
these data demonstrate that KIR3DS1  +   NK cells can recog-
nize HIV-1  –  infected HLA-Bw4  +   CD4  +   T cells. 
  To further evaluate the ability of KIR3DS1  +   cells to rec-
ognize HIV-1  –  infected target cells in the context of HLA-B 
Bw4-80I, we infected 221 cells that were either untrans-
fected or transfected with individual   HLA class I   alleles 
with a pseudotyped R5 virus (JRCSF). HIV-1  –  infected and 
  –  uninfected 221 cells were chromium labeled and placed 
in co-culture with the NK tumor cell line NKL express-
ing either KIR3DS1, KIR3DL1, or neither of the receptors 
for 6 h (  19, 21  ). The level of virus-associated target cell 
lysis by the eff  ector NK cells was calculated as a ratio of the 
percent lysis of HIV-1  –  infected versus   –  uninfected HLA-
transfected 221 cells. Target cell lysis, irrespective of the 
expressed HLA class I allotype, did not signifi  cantly diff  er 
between infected and uninfected 221 cells when exposed 
to KIR3DL1  +   or KIR3DL1  neg  /KIR3DS1  neg   NKLs (mean 
ratios of lysis of infected/uninfected cells were 1.01, 0.82, 
and 0.98 for KIR3DL1  +   NKLs, and 0.93, 0.88, and 1.01 
for KIR3DL1  neg  /KIR3DS1  neg   NKLs with respect to the   lysis 
of HLA-B Bw4-80I  –  , Bw4-80T  –  , and Bw6-  transfected 221 
cells, respectively). Furthermore, there was no increase in 
the level of killing by KIR3DS1  +   NKLs of HIV-1  –  infected 
221 cells transfected with either Bw4-80T or Bw6 compared 
with uninfected 221 cells (  Fig. 4 D  ). In contrast, KIR3DS1  +   
NKLs lysed HIV-1  –  infected 221 cells expressing HLA-B 
Bw4-80I signifi  cantly more effi   ciently than uninfected Bw4-
80I  +   221 cells (  Fig. 4 D   and Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20070695). Collectively, 
these data using both primary NK cells and KIR-transfected 
NKLs demonstrate that KIR3DS1  +   NK cells can recog-
nize and lyse HIV-1  –  infected target cells in the context of 
HLA-B Bw4-80I. 
    DISCUSSION   
  NK cells play a crucial role in the control of several human 
viral infections, but their functional role in HIV-1 pathogen-
esis is not known. In this paper, we demonstrate that NK 
cells expressing KIR3DS1, which has recently been shown to 
be expressed on the surface of NK cells (  20, 29  ) and to confer 
activating signals to NK cells (  19  ), are strongly   activated by 
autologous HIV-1  –  infected Bw4-80I  +   CD4  +   T cells and can 
signifi  cantly inhibit HIV-1 replication in these cells in vitro 
compared with NK cells expressing the inhibitory receptor 
KIR3DL1, or neither of these receptors. These data provide 
the fi  rst functional correlation and a   plausible mechanistic basis 
for the epidemiological studies that described a protective ef-
fect of the KIR3DS1/HLA-B Bw4-80I compound genotype JEM VOL. 204, November 26, 2007 
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  required to investigate the infl  uence of these additional NK 
cell receptors on the quality of KIR3DS1-mediated protection 
from HIV-1 disease. 
  To date, immunological studies in HIV-1 infection have 
largely focused on virus-specifi  c T cell and antibody re-
sponses. Our functional data suggest that, in addition to these 
adaptive immune responses, NK cells can contribute to the 
antiviral immunity against HIV-1, as suggested by recent epi-
demiological studies (  7, 31  ). NK cells have been shown to 
play a critical role in the initial containment of viral replica-
tion in several viral disease models (  25, 45  ). In acute HIV-1 
infection, NK cells are signifi  cantly expanded before the 
development of vigorous adaptive immunity (  46  ), indicating 
a potential role for the innate immune response in the initial 
control of viral replication. Studies aimed at investigating the 
role of CD8  +   T cells in the control of SIV/HIV infection 
demonstrated a lack of control over viral replication in rhesus 
macaques depleted of CD8  +   cells, and the results from these 
studies were interpreted as demonstrating that CD8  +   T cells 
are critical for control over SIV replication (  47, 48  ). However, 
the antibody used for these studies, CM-T807 (  47, 48  ), de-
pleted all cells expressing CD8 on their surface, as acknowledged 
by the authors. In monkeys,   >  80% of NK cells express CD8, 
resulting in their depletion in this experimental system. Thus, 
it is possible that not only the depletion of CD8  +   T cells 
alone but also of NK cells might have been responsible for 
or contributed to the loss of control of HIV-1 replication ob-
served in these studies. 
  In conclusion, a better understanding of the factors that 
contribute to the control of HIV-1 replication and the speed 
of HIV-1 disease progression is needed to guide the design of 
eff  ective immunotherapeutic interventions or vaccines. In this 
paper, we show compelling evidence that NK cells can limit 
HIV-1 replication in vitro and provide an initial functional 
correlate for the protective eff  ect of the   KIR3DS1/HLA-B 
Bw4-80I   compound genotype from HIV-1 disease  progression 
described in epidemiological studies (  7  ). These data suggest a 
more important role of eff  ector cells of the innate immune 
system in the control of HIV-1 replication than traditionally 
thought, which will help to guide the development of anti-
viral strategies directly targeting innate immunity. 
  MATERIALS AND METHODS 
  Subjects.     36 HIV-1  –  negative subjects were recruited for this study. The 
study was approved by the local Institutional Review Boards of the partici-
pating institutions, and all individuals gave informed consent for participa-
tion in this study. 
  HLA and KIR typing.     Genomic DNA was extracted from whole PBMCs 
and was typed for both KIR and HLA class I alleles. In brief, HLA typing 
was performed after amplifi  cation of genomic DNA using locus-specifi  c 
primers that fl  anked exons 2 and 3. The PCR products were blotted on 
  nylon membranes and hybridized with sequence-specifi  c oligonucleotide 
(thianthrene 5-oxide [SSO]) probes. We assigned alleles by the reaction pat-
terns of the SSO probes. Ambiguous SSO probe typing results were resolved 
by sequencing analysis, as previously described (  5  ). For KIR typing, genomic 
DNA was typed for the presence or absence of   KIR3DL1   and   KIR3DS1   
by PCR with sequence-specifi  c priming. PCR amplifi  cation was performed 
required to determine the underlying mechanism of the pro-
tective eff  ect of high expressing KIR3DL1 with HLA-B Bw4 
80I alleles in HIV-1 disease progression. 
  In line with the better in vitro inhibition of viral replica-
tion, KIR3DS1  +   NK cells were preferentially activated by 
HIV-1  –  infected Bw4-80I  +   target cells, because NK cells ex-
pressing KIR3DS1 (DX9  neg  z27  lo  ) specifi  cally degranulated 
in the presence of HIV-1  –  infected autologous CD4  +   T cells. 
Furthermore, only KIR3DS1-transfected NKLs and not 
KIR3DL1 or untransfected NKLs preferentially lysed HIV-1  –
  infected Bw4-80I  +   cells, but not uninfected Bw4-80I  +   cells. 
How might KIR3DS1  +   NK cells recognize HIV-1  –  infected 
CD4  +   T cells? The activating NK cell receptor KIR3DS1 
and the inhibitory receptor KIR3DL1 segregate as alleles of 
the same gene. KIR3DL1 binds to HLA-B molecules with 
the Bw4 motif and preferentially to the Bw4-80I subset of 
alleles (  21, 22  ). Allele-specifi  c, as well as peptide-dependent, 
binding between HLA class I molecules from the Bw4-80I 
family and KIR3DL1 have been recently described in the 
context of several diff  erent HLA class I epitopes derived from 
HIV-1 (  22, 35  ). KIR3DS1 and KIR3DL1 share     97% amino-
acid similarity in their extracellular domains (  7  ) and may, 
therefore, also share a similar set of ligands, as described for 
other families of activating and inhibitory KIRs (  18, 35  –  37  ). 
The observation that KIR3DS1  +   NK cell populations, as well as 
KIR3DS1-transfected NKLs, responded to HLA-B Bw4-80I  +   
HIV-infected target cells raises the possibility that specifi  c modi-
fi  cations of the HLA-B Bw4 80I  –  peptide complex occur during 
HIV-1 infection, leading to KIR3DS1 recognition/activation. 
Several reports have demonstrated that amino-acid changes 
at positions 7 and 8 within an epitope can have a profound 
eff  ect on inhibitory KIR recognition and, thus, NK cell acti-
vation (  38  –  40  ). Along the same line, it is possible that activat-
ing KIR signaling may also be infl  uenced by specifi  c peptides 
within the HLA-binding groove. Thus, it is plausible that viral 
or stress peptides produced during HIV-1 infection may be 
recognized by KIR3DS1 in the context of HLA-B Bw4-80I 
molecules, either directly or in conjunction with other re-
ceptors (  41  ). 
  Although individuals with the KIR3DS1/HLA-B Bw4 
80I haplotype suppressed HIV-1 replication more eff  ectively 
in vitro than subjects that expressed only one or neither of 
these two alleles, there was considerable heterogeneity in NK 
cell  –  mediated viral inhibition among these individuals. One 
potential explanation for this heterogeneity is that the quality 
of the KIR3DS1  +   NK cell  –  mediated inhibition of HIV-1 
might be signifi  cantly modulated by the presence of addi-
tional receptors expressed on these NK cells (  33, 34  ). Our 
data show that KIR3DS1  +  /3DL1  neg   express and transcribe 
additional inhibitory KIR and NKG2A (Fig. S4, available at 
http://www.jem.org/cgi/content/full/jem.20070695). The 
expression of these additional self-recognizing NK cell recep-
tors, as well as natural cytotoxicity receptors, is necessary for 
the effi   cient education/licensing of these NK cells (  42, 43  ), 
as well as their cross talk with DCs (  44  ), both of which ulti-
mately modulate their antiviral activity. Larger studies are 3034 NK CELL  –  MEDIATED INHIBITION OF HIV-1 | Alter et al.
  Cell lysis assay.     The lytic activity of NKLs against 221 target cells was as-
sessed by a standard chromium release assay, as previously described (  49  ). 
Thus, 2   ×   10  6   221 cells were labeled with 50      Ci Na  2  (  51  CrO  4  ) (1 Ci = 37 
GBq; New England Nuclear) for 1 h at 37  °  C, 5% CO  2  . Target cells were 
washed three times and plated with eff  ector NKLs at an E/T ratio of 20:1. 
Supernatant was harvested after a 6-h incubation at 37  °  C, 5% CO  2  . The 
percent lysis was calculated as follows: ([sample count   −   spontaneous release]/
[maximal release   −   spontaneous release])   ×   100. 
  Statistical analysis.     All experiments represent the mean of at least three 
experiments and standard deviations. To test for diff  erences in the mean 
  between several populations, a one-way analysis of variance with a Tukey  ’  s 
correction was used for all comparisons that were below P   <   0.05. P   <   0.05 
was considered signifi  cant. 
  Online supplemental material.     Fig. S1 shows data on NK cell numbers 
and activation markers over the 14-d co-culture period. Fig. S2 depicts the 
gating strategy used for the identifi  cation of p24  +   T cells (A), the loss of 
p24  +   T cells in wells containing autologous NK cells (B), as well as the 
overall p24 levels in infected T cells among HLA-KIR compound geno-
types (C). Fig. S3 demonstrates the raw data for the NKL lysis assay pre-
sented in  Fig. 4 D . Fig. S4 shows the protein (A) and mRNA (B) expression 
of additional inhibitory NK cell receptors in bulk NK cells and sorted sub-
populations. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20070695/DC1). 
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